Table 1 Baseline demographic and clinical characteristics of the KD and control groups.
Control group (n = 63) | KD group (n = 73) | P | |
|---|---|---|---|
Age of onset (year) | 0.92(0.42–2.25) | 0.80(0.55–1.26) | 0.84 |
Gender | 0.99 | ||
Male (%) | 60.3(38/63) | 60.3(44/73) | |
Female (%) | 39.7(25/63) | 39.7(29/73) | |
Etiology | 0.06 | ||
Hereditary/Metabolic (%) | 23.8(15/63) | 39.7(29/73) | |
Structural (%) | 47.6(30/63) | 26.0(19/73) | |
Infection/Immunity (%) | 4.8(3/63) | 4.1(3/73) | |
Unknown (%) | 23.8(15/63) | 30.1(22/73) | |
Baseline seizure frequency | 90.00(13.00–96.00) | 90.00(90.00–99.00) | 0.43 |
Seizure type | 0.14 | ||
Focal (%) | 27.3(38/139) | 20.3(32/158) | |
Spasms (%) | 25.9(36/139) | 34.8(55/158) | |
Tonic (%) | 3.6(5/139) | 8.9(14/158) | |
Clonic (%) | 2.2(3/139) | 3.2(5/158) | |
Myoclonic (%) | 10.8(15/139) | 8.9(14/158) | |
Absence (%) | 9.4(13/139) | 3.8(6/158) | |
Tonic-clonic (%) | 10.1(14/139) | 10.8(17/158) | |
Tonic-spasms (%) | 7.2(10/139) | 4.4(7/158) | |
Status epilepticus (%) | 3.6(5/139) | 5.1(8/158) | |
No. Seizure type (IQR) | 2.00(1.00–3.00) | 2.00(1.00–3.00) | 0.64 |
Disease duration (year) | 2.50(0.75-4.00) | 2.40(1.90–3.65) | 0.18 |
Types of ASMs (species) | 4.00(3.00–5.00) | 4.00(3.00–5.00) | 0.46 |
Change of Weight (Kg) | 0.50(0.00-1.50) | 1.00(0.50–1.83) | 0.24 |
Change of Height (cm) | 3.00(2.00–6.00) | 4.00(2.00–7.00) | 0.25 |
